Article Download
Nuvia aPrime 4A: An Innovative Solution for mAb Purification
The therapeutics industry has been seeking advanced chromatography resins to make downstream monoclonal antibody (mAb) purification more cost- and time-effective. Through a comparative purification study of acidic and basic mAbs on mixed-mode hydrophobic anion-exchange resins, we present Nuvia aPrime 4A as an innovative solution to improve your process productivity and economy.
Read this case study to learn more about:
- The selective and reversible binding of both acidic and basic mAbs on Nuvia aPrime 4A, in bind-elute or flow-through mode
- How Nuvia aPrime 4A achieved maximal purity and recovery, outperforming two other resins of its class
- How Nuvia aPrime 4A allows flexible and straightforward method development to purify the most complex molecules
Download the Article
Share a little information with us to access the entire article now.
Content you'll also find interesting
Recommended Features
-
Image
Optimizing mAb Purity and Recovery with Mixed-Mode Resins
Discover how mixed-mode approaches can streamline your purification workflow, increase efficiency and recovery of antibodies.
-
Image
Monoclonal Antibody Purification Guide
Optimize your antibody purification strategy with our antibody purification guide for selecting resins ideal for capture, intermediate, and polish.
-
Image
Simplifying Antibody Purification: Alternative to 3-Step Process
Learn how a two-step mixed-mode chromatography approach can simplify antibody purification without compromising purity or yield.
